Go Pro
→ NASA's ISS Replacement Could Go to This Tiny Space Firm (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.69
-0.6%		$1.25
$1.00
▼
$2.23
$21.43M1.652.48 million shs619,598 shs
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$4.88
-2.9%		$5.26
$4.59
▼
$8.31
$73.63M0.413,032 shs3,708 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.36
-2.2%		$1.35
$0.99
▼
$2.99
$69.13M0.82189,356 shs119,024 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.11
$1.62
$1.09
▼
$4.94
$57.18M1.43281,440 shs504,370 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-6.59%+12.58%+39.34%+51.79%+1.19%
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-5.01%+1.52%+1.25%-17.35%-24.44%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-6.08%+23.01%+0.72%-8.55%+138,999,900.00%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-2.63%0.00%-33.13%-34.71%-65.85%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.69
-0.6%		$1.25
$1.00
▼
$2.23
$21.43M1.652.48 million shs619,598 shs
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$4.88
-2.9%		$5.26
$4.59
▼
$8.31
$73.63M0.413,032 shs3,708 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.36
-2.2%		$1.35
$0.99
▼
$2.99
$69.13M0.82189,356 shs119,024 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.11
$1.62
$1.09
▼
$4.94
$57.18M1.43281,440 shs504,370 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-6.59%+12.58%+39.34%+51.79%+1.19%
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-5.01%+1.52%+1.25%-17.35%-24.44%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-6.08%+23.01%+0.72%-8.55%+138,999,900.00%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-2.63%0.00%-33.13%-34.71%-65.85%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.00
Hold$6.00255.03% Upside
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
1.00
SellN/AN/A
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
2.60
Moderate Buy$5.00267.65% Upside
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
2.33
Hold$6.00440.54% Upside

Current Analyst Ratings Breakdown

Latest BNGO, CSBR, HYFT, and RPID Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
9/16/2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D)
9/2/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
8/18/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
7/29/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/28/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/20/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/17/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/15/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/30/2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$30.18M0.66N/AN/A$4.37 per share0.39
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$60.66M1.12$0.01 per share363.67$0.32 per share15.23
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$16.23M3.91N/AN/A$0.11 per share12.36
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$35.18M1.58N/AN/A$0.75 per share1.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$26.40M-$3.02N/AN/AN/A-106.58%-78.78%-48.54%10/29/2026 (Estimated)
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-$1.17M-$0.08N/AN/AN/A-1.82%-25.77%-3.71%N/A
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$10.11M-$0.26N/AN/AN/A-105.11%-133.26%-77.78%N/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$47.12M-$1.12N/AN/AN/A-145.56%-177.04%-73.12%11/6/2026 (Estimated)

Latest BNGO, CSBR, HYFT, and RPID Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/14/2026Q1 2027
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$0.05-$0.09-$0.04-$0.09$3.25 million$2.73 million
9/10/2026Q1 2027
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-$0.01$0.05+$0.06-$0.03$15.05 million$15.23 million
8/10/2026Q2 2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$0.67-$0.64+$0.03-$0.64$7.55 million($6.67) million
8/7/2026Q2 2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.2433-$0.27-$0.0267-$0.27$7.88 million$8.05 million
7/27/2026Q4 2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-$0.05$0.01+$0.06-$0.05$12.89 million$13.84 million
7/22/2026Q4 2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$0.05-$0.06-$0.01-$0.06N/A$3.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
N/AN/AN/AN/AN/A
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
N/AN/AN/AN/AN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.11
2.48
1.96
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
N/A
1.03
1.03
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
0.43
1.84
1.75
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
1.08
2.55
1.51

Institutional Ownership

CompanyInstitutional Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
41.30%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.70%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
52.60%

Insider Ownership

CompanyInsider Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.65%
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
46.30%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.83%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
12.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
9711.78 million11.70 millionNo Data
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
21413.92 million7.48 millionOptionable
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
7746.71 million43.52 millionN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
17150.16 million43.79 millionNot Optionable

Recent News About These Companies

Comparing Thermo Fisher Scientific (NYSE:TMO) and Rapid Micro Biosystems (NASDAQ:RPID)
September 21 at 4:29 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036463
Reviewing MaxCyte (NASDAQ:MXCT) & Rapid Micro Biosystems (NASDAQ:RPID)
September 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31022756
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
September 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/04/3356790/33206/en/rapid-micro-biosystems-to-participate-in-upcoming-investor-conferences.html
After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)
September 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2985015/after-plunging-33-7-in-4-weeks-here-s-why-the-trend-might-reverse-for-rapid-micro-biosystems-rpid?cid=cs-stocknewsapi-ft-fundamental_analysis|rsi-2985015
Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2976813/down-25-7-in-4-weeks-here-s-why-you-should-you-buy-the-dip-in-rapid-micro-biosystems-rpid?cid=cs-stocknewsapi-ft-fundamental_analysis|rsi-2976813
Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973708/rapid-micro-biosystems-rpid-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-2973708
Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary
August 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/rapid-micro-biosystems-inc-q2-210247606.html
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970787/rapid-micro-biosystems-inc-rpid-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2970787
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
August 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341032/33206/en/rapid-micro-biosystems-reports-second-quarter-2026-financial-results.html
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338867/33206/en/rapid-micro-biosystems-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332637/33206/en/rapid-micro-biosystems-to-announce-second-quarter-2026-financial-results-on-august-7-2026.html
Rapid Micro Biosystems (RPID)
June 24, 2026  |  zacks.comhttps://www.zacks.com/stock/chart/RPID/broker-recommendations
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4-1036240610
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/10/3310119/33206/en/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html
Rapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potential
May 19, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/rapid-micro-biosystems-prices-9-8m-capital-raise-with-up-to-21-7m-in-additional-warrant-potential/ar-AA23xohy
Rapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and Warrants
May 18, 2026  |  quiverquant.comQ
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
May 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/19/3297111/33206/en/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering.html
Rapid Micro Biosystems Earnings Call Balances Growth And Risk
May 16, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/RPID/pressreleases/1968086/rapid-micro-biosystems-earnings-call-balances-growth-and-risk/
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/rapid-micro-biosystems-q1-2026-213143024.html
Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/rapid-micro-biosystems-inc-rpid-050204433.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$1.69 -0.01 (-0.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.70 +0.02 (+0.89%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Champions Oncology stock logo

Champions Oncology NASDAQ:CSBR

$4.88 -0.15 (-2.89%)
Closing price 03:59 PM Eastern
Extended Trading
$5.04 +0.16 (+3.28%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

MindWalk stock logo

MindWalk NASDAQ:HYFT

$1.36 -0.03 (-2.16%)
Closing price 04:00 PM Eastern
Extended Trading
$1.38 +0.02 (+1.62%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Rapid Micro Biosystems stock logo

Rapid Micro Biosystems NASDAQ:RPID

$1.11 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.11 0.00 (0.00%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas